Circle DNA, a joint venture between Berry Genomics and Prenetics, launched a consumer genetic test in China on April 22, 2019. The service utilises Whole Exome Sequencing (WES) to provide reports on disease risks and personal health.
- Technology: The test uses Whole Exome Sequencing (WES) to analyze genetic data across 20 categories, including cancer risk, carrier screening, and dietary sensitivities.
- Distribution: The launch includes a strategic partnership with JD.com to integrate genetic testing into the platform’s health offerings for its consumer base.
- Education: A group of regional public figures has joined the initiative to lead awareness programs focused on the use of genetics in proactive health management.
This summary is based on a press release issued by Prenetics.